ACTA1 and Myocardial fibrosis: Accordingly, Masson staining results demonstrated that MA treatment inhibited the TAC-induced myocardial fibrosis (Figure 2F), which was confirmed by decreased mRNA (Figure 2G) and protein (Figure 2H) expression of Fibronectin, Collagen I, and α-SMA.